Among the set of immunohistochemical markers, GATA3 and KRT5/6 have emerged as an effective surrogate molecular classifier of bladder cancer that correctly identified the molecular subtypes in over 80% of the cases. The gene discussed is GATA3; the disease is urinary bladder carcinoma.